|
|
Article: Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation.
- Article from:
- PR Newswire
- Article date:
- October 2, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DETROIT, Oct. 2 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the previously announced settlement of the legal proceedings related to LexaproA' (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ("APA") transaction with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's Inwood line of business. The ANDA patent litigation settlement resolves litigation involving Caraco, Forest, Forest Holdings, Ltd., and H. Lundbeck A/S and Sun Pharmaceutical Industries Limited ("Sun"). Caraco is a subsidiary of Sun.
As previously disclosed, among other things, with ...
Related newspaper, magazine, and journal articles:
|
|
Article: Has added Caraco Pharmaceutical Laboratories ...
M2 Presswire;
January 30, 2008 ;
700+ words
... ... Strategies: Has added Caraco Pharmaceutical Laboratories Ltd. to their watch list ... s activity has brought Caraco Pharmaceutical Laboratories Ltd. on our radar. Caraco Pharmaceutical Laboratories Ltd. was up over 4% with ...
|
|